Literature DB >> 21518742

What are the costs of heart failure?

Frieder Braunschweig1, Martin R Cowie, Angelo Auricchio.   

Abstract

Heart failure , a syndrome associated with increasing prevalence, high mortality, and frequent hospital admissions, imposes a significant economic burden on western healthcare systems that is expected to further increase in the future due to the ageing population. Hospitalizations are responsible for the largest part of treatment costs and, thus, the main target for strategies aiming at cost reduction. Current literature suggests that evidence-based therapy with drugs, devices, and modern disease management programmes improves clinical outcomes of the large population of heart failure patients in a largely cost-effective manner. However, comprehensive knowledge about the cost of treatment is important to guide clinicians in the responsible allocation of today's limited health-care resources. This review provides information about the total cost of heart failure and the contribution of different treatment components to the overall costs.

Entities:  

Mesh:

Year:  2011        PMID: 21518742     DOI: 10.1093/europace/eur081

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  62 in total

1.  HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria.

Authors:  Andreas Von der Heidt; Elske Ammenwerth; Karl Bauer; Bettina Fetz; Thomas Fluckinger; Andrea Gassner; Willhelm Grander; Walter Gritsch; Immaculata Haffner; Gudrun Henle-Talirz; Stefan Hoschek; Stephan Huter; Peter Kastner; Susanne Krestan; Peter Kufner; Robert Modre-Osprian; Josef Noebl; Momen Radi; Clemens Raffeiner; Stefan Welte; Andreas Wiseman; Gerhard Poelzl
Journal:  Wien Klin Wochenschr       Date:  2014-11-13       Impact factor: 1.704

2.  Heart Failure Among Older Adults in Skilled Nursing Facilities: More of a Dilemma Than Many Now Realize.

Authors:  Nicole M Orr; Daniel E Forman; Giuseppe De Matteis; Giovanni Gambassi
Journal:  Curr Geriatr Rep       Date:  2015-09-29

3.  The seasonal variation in hospitalizations due to chronic systolic heart failure correlates with blood sodium levels and cardiac function.

Authors:  Qingyan Zhao; Shengbo Yu; He Huang; Hongying Cui; Mu Qin; Bin Kong; Congxin Huang
Journal:  Exp Clin Cardiol       Date:  2013

4.  Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?

Authors:  Farhan Shahid; Gregory Y H Lip
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 5.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

6.  [Epidemiology and prognosis of heart failure].

Authors:  F Edelmann
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

7.  Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.

Authors:  Robert J Mentz; Emily C O'Brien
Journal:  J Am Coll Cardiol       Date:  2016-07-19       Impact factor: 24.094

Review 8.  Drug therapies in chronic heart failure: a focus on reduced ejection fraction.

Authors:  Helena Bolam; Geraint Morton; Paul R Kalra
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

9.  Systematic review of economic burden of heart failure.

Authors:  Asrul Akmal Shafie; Yui Ping Tan; Chin Hui Ng
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

Review 10.  Regenerative principles enrich cardiac rehabilitation practice.

Authors:  Atta Behfar; Andre Terzic; Carmen M Perez-Terzic
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.